Comparison of Different Anesthetic Techniques on Hearing Outcomes in Neonates After Cesarean Delivery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-35
SponsorSecond Affiliated Hospital of Wenzhou Medical University

About this trial

This is a single-center, prospective, single-blind randomized controlled trial. The investigators plan to recruit 144 pregnant women scheduled for cesarean delivery. Participants will be randomly assigned to receive either combined spinal-epidural anesthesia (CSEA) or general anesthesia (GA). The study aims to compare the effects of these two anesthetic techniques on neonatal hearing after cesarean delivery. The investigators will collect neonatal transient evoked otoacoustic emission (TEOAE) screening results and conduct follow-up hearing assessments at 3-6 months of age for infants who fail repeat screening. The investigators will also record maternal intraoperative hemodynamic changes, the interval from anesthesia initiation to neonatal delivery, neonatal Apgar scores at 1 and 5 minutes, and maternal postoperative pain scores at multiple time points.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

Refusal to participate;

Contraindications to neuraxial anesthesia;

Severe comorbidities, including hypertensive disorders of pregnancy, cardiovascular disease, hepatic or renal dysfunction, or coagulation abnormalities;

History of psychiatric disorders, severe anxiety or depression, or chronic preoperative use of sedative or analgesic medications;

Trial design

Design model

Parallel

Treatments tested in this trial

  • Combined spinal-epidural anesthesia

    Procedure/Surgery

    Combined spinal-epidural anesthesia is administered for elective cesarean section according to the study protocol

  • General Anesthesia (GA)

    Procedure/Surgery

    General anesthesia performed for cesarean delivery

Treatment groups

144 Participants
are divided into 2 treatment groups
Group A: Combined Spinal-Epidural Anesthesia Group (CSEA Group)Active comparator 1 intervention
Group B: General Anesthesia Group (GA Group)Active comparator 1 intervention

Trial outcomes

Primary outcomes

1

1. Neonatal hearing screening pass rate by transient evoked otoacoustic emission (TEOAE)

The pass rate of neonatal transient evoked otoacoustic emission (TEOAE) hearing screening within 72 hours after birth.

Time frame
Within 72 hours after delivery

Secondary outcomes

1

Maternal intraoperative hemodynamic changes

Changes in maternal blood pressure and heart rate during cesarean section.

Time frame
during surgery
2

Neonatal Apgar scores

Apgar scores will be assessed at 1 and 5 minutes after birth. The Apgar score evaluates five components: Appearance, Pulse, Grimace, Activity, and Respiration. The total score ranges from 0 to 10, with higher scores indicating better neonatal condition and a better outcome.

Time frame
1 minute and 5 minutes after birth
3

Postoperative maternal VAS pain score

Postoperative maternal pain intensity will be assessed using the Visual Analog Scale (VAS) at 1, 6, 12, 24, and 48 hours after cesarean delivery. The VAS ranges from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. Higher scores indicate greater pain intensity and therefore a worse outcome.

Time frame
1 hour, 6 hours, 12 hours, 24 hours and 48 hours after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.